If AI becomes table stakes, where is the differentiation? A Perspective

As AI-enabled molecule design becomes increasingly commoditized, these tools will end up doing less to set companies apart than to raise the baseline for everyone. Differentiation will likely move upstream to proprietary biology and data, and downstream to assays and iteration speed. The key question is whether AI changes the industry’s questions, or simply helps answer the same ones faster, intensifying industry’s crowding problem.

Broader access to AI design and optimization could open up chemical territory, creating more room for differentiation and encouraging exploration of new targets. Or it could accelerate the race toward the same targets and push companies toward similar molecular designs...